An exploratory study of the biologic effects of nivolumab (Anti-PD-1; BMS-936558; ONO-4538) treatment in patients (pts) with advanced (unresectable or metastatic) melanoma (MEL) Meeting Abstract


Authors: Sosman, J. A.; Martin-Algarra, S.; Wolchok, J. D.; Sharfman, W. H.; Bhatia, S.; Hodi, F. S.; Hwu, W. J.; Gajewski, T.; Slingluff, C. L.; Kaufman, H.; Gupta, M.; McGirr, A.; Horak, C. E.; Ahlers, C. M.; Wigginton, J. M.; Urba, W. J.
Abstract Title: An exploratory study of the biologic effects of nivolumab (Anti-PD-1; BMS-936558; ONO-4538) treatment in patients (pts) with advanced (unresectable or metastatic) melanoma (MEL)
Meeting Title: 49th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 31
Issue: 15 Suppl.
Meeting Dates: 2013 May 31-Jun 4
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2013-05-20
Language: English
ACCESSION: WOS:000335419605408
PROVIDER: wos
DOI: 10.1200/jco.2013.31.15_suppl.TPS3114
Notes: Meeting Abstract: TPS3114 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Jedd D Wolchok
    905 Wolchok